Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Nabriva Therapeutics (NBRV) - Total debt
Total debt on the balance sheet as of March 2023 : $0.54 M
According to Nabriva Therapeutics 's latest financial reports the company's total debt is $0.54 M. A company’s total debt is the sum of all current and non-current debts.
Nabriva Therapeutics - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $5.22 M | -34.98% |
| 2021-12-31 | $8.03 M | 3.92% |
| 2020-12-31 | $7.72 M | -77.6% |
| 2019-12-31 | $34.5 M | 45.47% |
| 2018-12-31 | $23.71 M | 10123.28% |
| 2017-12-31 | $0.23 M | |
| 2014-12-31 | $26.81 M | 63.45% |
| 2013-12-31 | $16.4 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | 407.75% | 🇺🇸 USA |